CNR1 and fragile X syndrome: The endocannabinoid system facilitates synaptic homeostasis and plasticity through the cannabinoid receptor 1 (CB1) on presynaptic terminals, resulting in feedback inhibition of neuronal signaling, which are thought to be disrupted in FXS and may be restored by CBD acting as a negative allosteric modulator of CB1 [31].